The GLOBOCAN project is widely considered to be the best resource for global adult cancer data. GLOBOCAN estimates cancer incidence (number of new cases per year), mortality and prevalence (number of people living with that cancer) of 28 different cancer types in 184 countries around the world. The most recent estimates available are for 2008.
In 2008, there were an estimated 1.38 million new cases of breast cancer, 530,000 new cases of cervical cancer, and 225,000 new cases of ovarian cancer around the world.
The Global Breast Oncology Fund provides support to the Women's Empowerment Cancer Advocacy Network (WE CAN) and global outreach efforts to educate and promote awareness, care and treatment of breast cancer in UW Medicine's Division of Medical Oncology.
The BHGI, founded and led by the Fred Hutchinson Cancer Research Center and Susan G. Komen®, is an alliance dedicated to improving breast health care and cancer treatment for women in lower-income countries. The BHGI publishes Guidelines for International Breast Health and Cancer Control (link: http://onlinelibrary.wiley.com/doi/10.1002/cncr.v113:8+/issuetoc), freely available consensus guidelines for detection, diagnosis and treatment of breast cancer in resource-limited settings.
UICC is a large membership organization dedicated to fighting cancer around the world. Founded in 1933, UICC includes 760 member organizations from 155 different countries. The organization sponsors a biannual World Cancer Congress to convene world leaders in global cancer control.
The National Cancer Institute (link: http://www.cancer.gov/) recently formed the Center for Global Health to better extend the NCI’s work on cancer research and care from the U.S. to the entire world. The Center for Global Health supports NCI's goal to advance global cancer research, build expertise, and leverage resources across nations to address the challenges of cancer and reduce cancer deaths worldwide. Enabling the open exchange of scientific knowledge is a critical goal in the fight against cancer. The Center for Global Health facilitates research efforts to decrease the global burden of cancer by collaborating with U.S. government agencies, foreign governments, non-government organizations, and pharmaceutical and biotechnology companies. The Center has established a portal to facilitate international collaborations on clinical trials (http://www.cancer.gov/clinicaltrials/international) and has collaborative research programs in Latin America, China, Japan, Ireland and the Middle East, among other regions.
The Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries is directed by partners at Harvard University, Fred Hutchinson Cancer Research Center, and the University of Washington. The organization’s goal is to increase access to cancer prevention, detection and treatment strategies in low and middle-income countries around the world. GTF.CCC’s agenda includes: improving awareness of cancer’s impact on the developing world; reducing human suffering from cancer by providing access to existing methods for palliative care and treatments for cancer patients in all parts of the world; defining essential treatments and services needed to provide cancer care in low-income settings; and preventing more cancers by reducing cancer risk factors, especially tobacco.
The organization has recently published a book, Closing the Cancer Divide: An Equity Imperative.
RPX’s mission is to equalize standards of health care, information access and participation in government around the world. This mission is accomplished by supporting and strengthening the activities of nonprofit organizations in developing regions. RPX provides international support in the form of technical and material resources, such as professional healthcare training, emergency food supplies, or carefully targeted medicines. As a principle differentiator, RPX operates through local partners and without establishing international offices or hiring expatriate staff. This approach has been shown to strengthen local capacity, promote local ownership, diminish administrative costs, and increase program sustainability.
About Susan G. Komen® - Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world’s largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure® and Komen 3-Day for the Cure®, we have invested more than $1.9 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world.
For more information about Susan G. Komen®, breast health or breast cancer, visit http://www.komen.org or call 1-877 GO KOMEN.